AU707675B2 - Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) - Google Patents
Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) Download PDFInfo
- Publication number
- AU707675B2 AU707675B2 AU21240/97A AU2124097A AU707675B2 AU 707675 B2 AU707675 B2 AU 707675B2 AU 21240/97 A AU21240/97 A AU 21240/97A AU 2124097 A AU2124097 A AU 2124097A AU 707675 B2 AU707675 B2 AU 707675B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- formulation
- formula
- desmoid
- fibromatoses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1077396P | 1996-01-29 | 1996-01-29 | |
US60/010773 | 1996-01-29 | ||
GB9603148 | 1996-02-15 | ||
GBGB9603148.9A GB9603148D0 (en) | 1996-02-15 | 1996-02-15 | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
PCT/US1997/002287 WO1997026878A1 (en) | 1996-01-29 | 1997-01-27 | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2124097A AU2124097A (en) | 1997-08-20 |
AU707675B2 true AU707675B2 (en) | 1999-07-15 |
Family
ID=26308707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU21240/97A Ceased AU707675B2 (en) | 1996-01-29 | 1997-01-27 | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0907361A4 (xx) |
JP (1) | JP2000503995A (xx) |
KR (1) | KR19990082055A (xx) |
CN (1) | CN1209746A (xx) |
AU (1) | AU707675B2 (xx) |
CZ (1) | CZ235398A3 (xx) |
EA (1) | EA199800678A1 (xx) |
IL (1) | IL125523A0 (xx) |
NO (1) | NO983452L (xx) |
PL (1) | PL328127A1 (xx) |
WO (1) | WO1997026878A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2135195C1 (ru) * | 1998-12-17 | 1999-08-27 | Овсюк Валерий Григорьевич | Способ получения материала, содержащего клетки предстательной железы, материал, содержащий клетки предстательной железы, и способы лечения фиброматоза матки, хронического простатита и нарушений мужской половой функции методом трансплантации |
AU781168B2 (en) | 2001-01-26 | 2005-05-12 | Pfizer Products Inc. | Method of treating certain cancers using an estrogen agonist/antagonist |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
US5552162A (en) * | 1993-02-09 | 1996-09-03 | Arch Development Corporation | Method for improvement of scar size and appearance |
US5457116A (en) * | 1993-10-15 | 1995-10-10 | Eli Lilly And Company | Methods of inhibiting uterine fibrosis |
CA2118096A1 (en) * | 1993-10-15 | 1995-04-16 | Srinivasan Chandrasekhar | Methods for treating resistant neoplasms |
US5574047A (en) * | 1993-12-21 | 1996-11-12 | Eli Lilly And Company | Methods of inhibiting imperfect tissue repair |
-
1997
- 1997-01-27 CZ CZ982353A patent/CZ235398A3/cs unknown
- 1997-01-27 KR KR1019980705776A patent/KR19990082055A/ko not_active Application Discontinuation
- 1997-01-27 EP EP97906588A patent/EP0907361A4/en not_active Withdrawn
- 1997-01-27 JP JP9527133A patent/JP2000503995A/ja active Pending
- 1997-01-27 CN CN97191916A patent/CN1209746A/zh active Pending
- 1997-01-27 WO PCT/US1997/002287 patent/WO1997026878A1/en not_active Application Discontinuation
- 1997-01-27 PL PL97328127A patent/PL328127A1/xx unknown
- 1997-01-27 IL IL12552397A patent/IL125523A0/xx unknown
- 1997-01-27 EA EA199800678A patent/EA199800678A1/ru unknown
- 1997-01-27 AU AU21240/97A patent/AU707675B2/en not_active Ceased
-
1998
- 1998-07-27 NO NO983452A patent/NO983452L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO983452D0 (no) | 1998-07-27 |
KR19990082055A (ko) | 1999-11-15 |
EP0907361A4 (en) | 2002-05-02 |
PL328127A1 (en) | 1999-01-18 |
WO1997026878A1 (en) | 1997-07-31 |
CN1209746A (zh) | 1999-03-03 |
EA199800678A1 (ru) | 1999-02-25 |
NO983452L (no) | 1998-07-27 |
JP2000503995A (ja) | 2000-04-04 |
AU2124097A (en) | 1997-08-20 |
CZ235398A3 (cs) | 1999-02-17 |
IL125523A0 (en) | 1999-03-12 |
EP0907361A1 (en) | 1999-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU699948B2 (en) | Methods of inhibiting atrophy of the skin and vagina | |
AU691844B2 (en) | Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome | |
AU692491B2 (en) | Methods of inhibiting CNS problems in post-menopausal women | |
AU701701B2 (en) | Methods of inhibiting breast disorders | |
US5451590A (en) | Methods of inhibiting sexual precocity | |
US5843974A (en) | Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se | |
US5670523A (en) | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) | |
AU707675B2 (en) | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) | |
AU690162B2 (en) | Methods of inhibiting hirsutism and alopecia in women | |
CA2244247A1 (en) | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) | |
CA2170480A1 (en) | Methods of inhibiting estrogen positive tumors of the brain or cns | |
AU707892B2 (en) | Methods of inhibiting colon tumors | |
CA2244112A1 (en) | Methods of inhibiting colon tumors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |